insights_auto
Why is EDIT down 4.09%?
Dive Deeperchevron_right
EDIT:NASDAQ
Editas Medicine Inc
$1.64
arrow_downward
-4.09%(-0.070) 1D
$1.66
arrow_upward
+1.22% (+0.020)bedtimeAfter hours
Closed: Nov 20, 4:00:00 PM GMT-5 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for EDIT...
Open
$1.69
High
$1.78
Low
$1.63
Mkt. cap
253.12M
Avg. vol.
2.24M
Volume
2.68M
52-wk high
$3.94
52-wk low
$1.63
EPS
-$0.62
Beta
2.09
Shares outstanding
154.34M
No. of employees
87
Open
$1.69
High
$1.78
Low
$1.63
Mkt. cap
253.12M
Avg. vol.
2.24M
Volume
2.68M
52-wk high
$3.94
52-wk low
$1.63
EPS
-$0.62
Beta
2.09
Shares outstanding
154.34M
No. of employees
87
News stories
From web sources and news partners
The Motley Fool
·
37 minutes ago
Report: Goldman Sachs Predicts the S&P 500 Will Gain 26% in 12 Months
marketscreener.com
·
48 minutes ago
Nasdaq has its worst week since 2020; Dow, S&P 500 in correction
Benzinga
·
1 hour ago
Veteran, 41, Put $500K Into The S&P 500. Dave Ramsey Says It Could Hit $8 By Age 69 ‘If You Just Don’t Touch It’
FXStreet
·
4 hours ago
Dow Jones Industrial Average drops for a fifth day as AI rout widens
Profile
Editas Medicine, Inc., is a clinical-stage biotechnology company that is developing therapies for rare diseases using CRISPR gene editing technology. Editas Medicine headquarters is located in Cambridge, Massachusetts with additional facilities in Boulder, Colorado. Wikipedia
About Editas Medicine Inc
CEO-
Employees87
FoundedNov 2013
Headquarters-
SectorHealth Care
IndustryBiotechnology
Websiteeditasmedicine.com